key: cord-0979123-1qy2uulw authors: Rogers, J. P.; Watson, C.; Badenoch, J.; Cross, B.; Butler, M.; Song, J.; Hafeez, D.; Morrin, H.; Rengasamy, E. R.; Thomas, L.; Ralovska, S.; Smakowski, A.; Sundaram, R. D.; Hunt, C. K.; Lim, M. F.; Aniwattanapong, D.; Singh, V.; Hussain, Z.; Chakraborty, S.; Burchill, E.; Jansen, K.; Holling, H.; Walton, D.; Pollak, T. A.; Ellul, M.; Koychev, I.; Solomon, T.; Michael, B. D.; Nicholson, T. R.; Rooney, A. G. title: The neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives date: 2021-02-26 journal: nan DOI: 10.1101/2021.02.24.21252335 sha: 809f1e294e2be84df6de769471c1e74469a1cfc9 doc_id: 979123 cord_uid: 1qy2uulw Objectives There is accumulating evidence of the neurological and neuropsychiatric features of infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations. Methods We searched MEDLINE, Embase, PsycInfo and CINAHL up to 18 July 2020 for randomised controlled trials, cohort studies, case-control studies, cross-sectional studies and case series. Studies reporting prevalences of neurological or neuropsychiatric symptoms were synthesised into meta-analyses to estimate pooled prevalence. Results 13,292 records were screened by at least two authors to identify 215 included studies, of which there were 37 cohort studies, 15 case-control studies, 80 cross-sectional studies and 83 case series from 30 countries. 147 studies were included in the meta-analysis. The symptoms with the highest prevalence were anosmia (43.1% [35.2-51.3], n=15,975, 63 studies), weakness (40.0% [27.9-53.5], n=221, 3 studies), fatigue (37.8% [31.6-44.4], n=21,101, 67 studies), dysgeusia (37.2% [30.0-45.3], n=13,686, 52 studies), myalgia (25.1% [19.8-31.3], n=66.268, 76 studies), depression (23.0 % [11.8-40.2], n=43,128, 10 studies), headache (20.7% [95% CI 16.1-26.1], n=64,613, 84 studies), anxiety (15.9% [5.6-37.7], n=42,566, 9 studies) and altered mental status (8.2% [4.4-14.8], n=49,326, 19 studies). Heterogeneity for most clinical manifestations was high. Conclusions Neurological and neuropsychiatric symptoms of COVID-19 in the pandemic's early phase are varied and common. The neurological and psychiatric academic communities should develop systems to facilitate high-quality methodologies, including more rapid examination of the longitudinal course of neuropsychiatric complications of newly emerging diseases and their relationship to neuroimaging and inflammatory biomarkers. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 26, 2021 0 0 0 0 -0 0 0 3 -3 2 9 3 -2 2 1 9 D r D a r u j A n i w a t t a n a p o n g I n s t i t u t e o f P s y c h i a t r y , P s y c h o l o g y a n d N e u r o s c i e n c e , K i n g ' s C o l l e g e L o n d o n , U K D e p a r t m e n t o f P s y c h i a t r y , F a c u l t y o f M e d i c i n e , C h u l a l o n g k o r n U n i v e r s i t y , B a n g k o k , T h a i l a n d h t t p s : / / o r c i d . o r g / 0 0 0 0 -0 0 0 2 -4 2 3 8 -7 6 0 8 M s V a n s h i k a S i n g h S e n i o r S u b -E d i t o r a n d S t a f f W r i t e r , h t t p s : / / o r c i d . o r g / 0 0 0 0 -0 0 0 2 -4 7 6 0 -5 8 2 X . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 3 T h e W i r e S c i e n c e D r Z a i n H u s s a i n E d i n b u r g h M e d i c a l S c h o o l , C o l l e g e o f M e d i c i n e a n d V e t e r i n a r y M e d i c i n e , U n i v e r s i t y o f E d i n b u r g h , U K h t t p s : / / o r c i d . o r g / 0 0 0 0 -0 0 0 2 -0 5 5 9 -8 2 8 9 M i s s S t u t i C h a k r a b o r t y D e p a r t m e n t o f P h y s i c a l M e d i c i n e a n d R e h a b i l i t a t i o n , C h r i s t i a n M e d i c a l C o l l e g e a n d H o s p i t a l , V e l l o r e , I n d i a h t t p s : a l t o n D e p a r t m e n t o f N e u r o l o g y , T h e W a l t o n C e n t r e N H S F o u n d a t i o n T r u s t , L i v e r p o o l , U K D r T h o m a s A P o l l a k D e p a r t m e n t o f P s y c h o s i s S t u d i e s I n s t i t u t e o f P s y c h i a t r y , P s y c h o l o g y a n d N e u r o s c i e n c e , K i n g ' s C o l l e g e L o n d o n D e C r e s p i g n y P a r k L o n d o n S E 5 4 A F h t t p s : / / o r c i d . o r g / 0 0 0 0 -0 0 0 2 -6 1 7 1 -0 8 1 0 D r M a r k E l l u l D e p a r t m e n t o f N e u r o l o g y , T h e W a l t o n C e n t r e N H S F o u n d a t i o n T r u s t , L i v e r p o o l , U K ; N a t i o n a l I n s t i t u t e f o r H e a l t h R e s e a r c h H e a l t h P r o t e c t i o n R e s e a r c h U n i t i n E m e r g i n g a n d Z o o n o t i c I n f e c t i o n , U n i v e r s i t y o f L i v e r p o o l , U K ; C l i n i c a l I n f e c t i o n M i c r o b i o l o g y a n d I m m u n o l o g y , I n s t i t u t e o f I n f e c t i o n , V e t e r i n a r y , a n d Z o o l o g i c a l S c i e n c e , U n i v e r s i t y o f L i v e r p o o CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) D r I v a n K o y c h e v D e p a r t m e n t o f P s y c h i a t r y , U n i v e r s i t y o f O x f o r d , O x f o r d , U K D e p a r t m e n t o f P s y c h o l o g i c a l M e d i c i n e , O x f o r d U n i v e r s i t y H o s p i t a l s N H S F o u n d a t i o n T r u s t , O x f o r d , U K h t t p s : / / o r c i d . o r g / 0 0 0 0 -0 0 0 1 -6 8 1 3 -8 4 9 e n e d i c t D a n i e l M i c h a e l D e p a r t m e n t o f N e u r o l o g y , T h e W a l t o n C e n t r e N H S F o u n d a t i o n T r u s t , L i v e r p o o l , U K ; N a t i o n a l I n s t i t u t e f o r H e a l t h R e s e a r c h H e a l t h P r o t e c t i o n R e s e a r c h U n i t i n E m e r g i n g a n d Z o o n o t i c I n f e c t i o n , U n i v e r s i t y o f L i v e r p o o l , U K ; C l i n i c a l I n f e c t i o n M i c r o b i o l o g y a n d I m m u n o l o g y , I n s t i t u t e o f I n f e c t i o n , V e t e r i n a r y , a n d Z o o l o g i c a l S c i e n c e , U n i v e r s i t y o f L i v e r p o o e u r o p s y c h i a t r y , I n s t i t u t e o f P s y c h i a t r y , P s y c h o l o g y a n d N e u r o s c i e n c e , K i n g ' s C o l l e g e L o n d o n , L o n d o n , U K h t t p s : . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 26, 2021. n e u r o p s y c h i a t r i c c o n s e q u e n c e s o f C O V I D -1 9 ? 2 . W h a t w a s t h e p r e v a l e n c e o f n e u r o l o g i c a l a n d n e u r o p s y c h i a t r i c c o m p l i c a t i o n s i n C O V I D -1 9 p a t i e n t s i n c e m a n a g e m e n t a n d R a y y a n Q B e t w e e n -s t u d y h e t e r o g e n e i t y w a s c a l c u l a t e d u s i n g t h e I 2 s t a t i s t i c . W e p l a n n e d a p r i o r i t o a n a l y s e t h e f o l l o w i n g s u b g r o u p s : r e t r o s p e c t i v e o r p r o s p e c t i v e d e s i g n , m e t h o d o f S A R S -C o V -2 d i a g n o s i s , s e v e r i t y o f C O V I D -1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 a b s e n t ' b y s t u d y a u t h o r s . T h e r o b u s t n e s s o f t h e m a i n a n a l y s e s w e r e a s s e s s e d b y r e p e a t i n g t h e a n a l y s e s o n h e a d a c h e , m y a l g i a , a n o s m i a , f a t i g u e a n d d y s g e u s i a u s i n g t h e s t a n d a r d r a n d o m -e f f e c t s m o d e l f o r m e t a -a n a l y s i s w i t . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 26, 2021 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 6 I n o u r r e v i e w w e s u m m a r i s e p o i n t p r e v a l e n c e o f 2 0 n e u r o l o g i c a l a n d n e u r o p s y c h i a t r i c c o m p l i c a t i o n s o f C O V I D -1 9 . T h e m o s t f r e q u e n t l y s t u d i e d s y m p t o m s w e r e h e a v i l y w e i g h t e d t o w a r d s n o n -s p e c i f i c f e a t u r e s o f s y s t e m i c i l l n e s s , s u c h a s h e a d a c h e , m y a l g i a , f a t i g u e , a n o s m i a a n d d y s g e u s i a . I t w a s p r e d o m i n a n t l y t h e s e m o r e n o n -s p e c i f i c s y m p t o m s t h a t w e r e f o u n d t o h a v e t h e h i g h e s t p r e v a l e n c e I n t e r m s o f p o p u l a t i o n s , t h e f r e q u e n t u s e o f h o s p i t a l i n p a t i e n t s i s u n r e p r e s e n t a t i v e o f t h e m a j o r i t y o f p a t i e n t s w i t h C O V I D -1 9 , w h o a r e n o t a d m i t t e d t o h o s p i t a l . R e g a r d i n g c l i n i c a l m a n i f e s t a t i o n s , t h e m a i n l i m i t a t i o n s w e r is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 h e t e r o g e n e i t y b e t w e e n s t u d i e s , e v e n a f t e r s u b g r o u p a n a l y s e s , s u g g e s t s t h a t v a r i a t i o n i n p o p u l a t i o n s , o u t c o m e s a n d m e a s u r e m e n t t e c h n i q u e s m i g h t a c c o u n t f o r m u c h o f t h e d i f f e r e n c e s b e t w e e n s t u d i e s . F i n a l l y , t h e c r o s s -s e c t i o n n e u r o p s y c h i a t r i c s y m p t o m s a r e v e r y c o m m o n w i t h f o u r ( a n o s m i a , w e a k n e s s , d y s g e u s i a a n d f a t i g u e ) e s t i m a t e d t o o c c u r i n m o r e t h a n 3 0 % o f p a t i e n t s . S e c o n d l y , t h e s e n o n -s p e c i f i c n e u r o l o g i c a l a n d n e u r o p s y c h i a t r i c s y m p t o m is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 Proportion of patients reporting headache in SARS−CoV−2 infection by patient severity . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuit (which was not certified by peer review) Proportion of patients reporting fatigue in SARS−CoV−2 infection by patient severity . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Proportion of patients reporting anosmia in SARS−CoV−2 infection by patient severity . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuit (which was not certified by peer review) The copyright holder for this pr this version posted February 26, 2021. Proportion of patients reporting dysguesia in SARS−CoV−2 infection by patient severity . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuit (which was not certified by peer review) The copyright holder for this pr this version posted February 26, 2021. ; https://doi.org/10.1101/2021.02.24.21252335 doi: medRxiv preprint A new coronavirus associated with human respiratory disease in China Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic Nervous system involvement after infection with COVID-19 and other coronaviruses Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Guillain-Barré Syndrome Associated with SARS-CoV-2 Neurologic Features in Severe SARS-CoV-2 Infection COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke Early neurological manifestations of hospitalized COVID-19 patients A prospective clinical study of detailed neurological manifestations in patients with COVID-19 Neurological associations of COVID-19 Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019 Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study The Neurology and Neuropsychiatry of COVID-19 Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14 Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement The Oxford Levels of Evidence 2 Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions The binomial distribution of meta-analysis was preferred to model within-study variability Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data R: A Language and Environment for Statistical Computing Conducting Meta-Analyses in R with the metafor Package Evaluation of the Patient with Muscle Weakness Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies Underdiagnosis of delirium on admission and prediction of patients who will develop delirium during their inpatient stay: a pilot study Identification of depression by medical and surgical general hospital physicians A call for a global COVID-19 Neuro Research Coalition Global COVID-19 Clinical Platform: Rapid core case report form (CRF) Persistent Symptoms in Patients After Acute COVID-19